SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Evexia Lifecare gets initial plant layout permission from FDA

31 Jul 2021 Evaluate

Evexia Lifecare has received initial plant layout permission from FDA to setup Active Pharmaceutical Ingredient (API) manufacturing plant of Isometamidium (Isometa) in addition to the current ongoing commercial activity.

The Isometamidium (ISOMETA) is mainly used for the rare dieses in the cattle, buffalo, goat, sheep, equines (horses, donkeys), camels and dogs. Very few players are manufacturing the said API in India as well as across the world. The company is going to set up a plant with the capacity of 400kg per month API which will be the highest production by any company. This API plant will increased the revenue of the company by 30-40 Cr p.a. as well as increased the profitability by good %. There is high demand of this API mainly in Middle East, Africa and Latin America. The advance stage negotiation is already going on with buyers for advance order of this API product.

The company is going to setup a large plant to manage the demand of ISOMETA across the globe. Evexia has strong technical background and good manufacturing facility for manufacturing of API and formulations. Evexia Lifecare will market this product with wide International contacts and expecting sizable market share. The company is aiming to supply 20% of the total demand of this API in future.

Evexia Lifecare manufactures edible oil. The company offers cottonseed, groundnut, mustard, soyabean, sunflower, and corn oil, as well as industrial oil.

Evexia Lifecare Share Price

0.73 0.03 (4.29%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 227.50
Adani Enterprises 2228.00
Amrapali Industries 17.36
Rashi Peripheral 474.40
PDS 294.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×